Technical Analysis of Stocks: SPY / QQQ / NVDA / TSLA / AMD / PLTR / HOOD / SPCX
3 extracted signals · 1 resolved · 2 still active
The Finance HydraIndependent analyst profile- Source published
- 10 Sept 2026, 23:00 UTC
- Recorded by Tahlil Plus
- 11 Sept 2026, 02:41 UTC
AI-generated source summary
The analysis focuses on key support and resistance levels for SPY, QQQ, and NVDA. SPY is currently reacting near a critical support level at 406.67, with a potential bullish bounce expected if it holds, targeting 408.75, while a break below 405.60 would invalidate the bullish short-term outlook. QQQ is also at a critical inflection point, trading near the 706.69 support level. A bullish reaction here could see it move towards 722.40, with 700.00 serving as the invalidation point. NVDA is identified as bullish, currently retesting its 21-day EMA. The prediction is for a continued rally towards its highs, possibly above 229.70, with a fail bound below 217.00. The overall market sentiment leans cautiously optimistic for individual stocks showing bullish potential despite broader market concerns.
AI-generated summary based on the source content.
Signal outcomes at a glance
Partially ResolvedSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
3 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Live evaluation in progress
2 signals remain active.
The Finance Hydra
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.